Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Abituzumab (DI17E6), a humanized IgG2-type anti-integrin αV monoclonal antibody, notably decreases phosphorylation of FAK, Akt, and ERK. Its application is significant in cancer research, with a particular emphasis on prostate cancer [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Abituzumab (DI17E6), a humanized IgG2-type anti-integrin αV monoclonal antibody, notably decreases phosphorylation of FAK, Akt, and ERK. Its application is significant in cancer research, with a particular emphasis on prostate cancer [1]. |
Molecular Weight | N/A |
CAS No. | 1105038-73-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Abituzumab 1105038-73-0 inhibitor inhibit